Literature DB >> 10368877

Exercise stress testing. An overview of current guidelines.

S A Lear1, A Brozic, J N Myers, A Ignaszewski.   

Abstract

Exercise stress testing (ET) is an inexpensive noninvasive tool that provides valuable cardiopulmonary information in healthy and diseased populations. It is most commonly used for diagnosing coronary artery disease (CAD) and developing appropriate exercise prescriptions (EP). With its widespread use and application, it is imperative that safe and appropriate guidelines and procedures are used, as there are a number of risks associated with testing in a population with or suspected of having CAD. The focus should be on the patient's safety: personnel must be properly trained and aware of all emergency procedures, contra-indications for ET and indications for test termination must be strictly adhered to. Three main types of testing are prevalent: submaximal, maximal and maximal utilising gas exchange. The maximal test is most commonly used, and the submaximal is appropriate for hospitalised patients. Gas exchange data is essential when assessing congestive heart failure and timing for heart transplantation. ET is commonly performed using a treadmill or a bicycle ergometer. The treadmill provides a more familiar exercise modality and has been shown to have greater diagnostic sensitivity than the bicycle ergometer; it is, however, more expensive and requires more space in the testing room. The bicycle ergometer is more appropriate for those individuals who are severely obese or have problems with extended periods of walking. Regardless of the modality used, an appropriate exercise protocol should be used. In North America, the Bruce protocol is the most common. However, the Bruce protocol, and others that estimate exercise capacity based on equations, tend to overestimate exercise capacity. They may be too demanding for those with limited exercise capacity, and too long for those with high exercise capacity. For these people, an exercise protocol that reaches maximal capacity in 8 to 12 minutes using smaller increments in workload should be considered. Once completed, the results of ET needs to be correctly interpreted. This includes reviewing the test results while considering the patient's history, medications and indication for the test. ET can also be used to develop an EP for the participant. An EP should take into account the intensity, modality of exercise, frequency and duration, as well as being realistic for the individual and the goals to be achieved. All the information from the test results and the pre-test examination should be presented in a report that also includes the advised EP.

Entities:  

Mesh:

Year:  1999        PMID: 10368877     DOI: 10.2165/00007256-199927050-00002

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  73 in total

1.  Estimating oxygen consumption during treadmill and arm ergometry activity in males with coronary artery disease.

Authors:  J Milani; B Fernhall; T Manfredi
Journal:  J Cardiopulm Rehabil       Date:  1996 Nov-Dec       Impact factor: 2.081

2.  Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults.

Authors:  H C Stary
Journal:  Arteriosclerosis       Date:  1989 Jan-Feb

3.  Exercise standards. A statement for healthcare professionals from the American Heart Association. Writing Group.

Authors:  G F Fletcher; G Balady; V F Froelicher; L H Hartley; W L Haskell; M L Pollock
Journal:  Circulation       Date:  1995-01-15       Impact factor: 29.690

Review 4.  1993 C.H. McCloy Research Lecture: physical activity, physical fitness, and health.

Authors:  S N Blair
Journal:  Res Q Exerc Sport       Date:  1993-12       Impact factor: 2.500

5.  The reproducibility of hemodynamic, electrocardiographic, and gas exchange data during treadmill exercise in patients with stable angina pectoris.

Authors:  M Sullivan; F Genter; M Savvides; M Roberts; J Myers; V Froelicher
Journal:  Chest       Date:  1984-09       Impact factor: 9.410

6.  Optimizing the exercise protocol for cardiopulmonary assessment.

Authors:  M J Buchfuhrer; J E Hansen; T E Robinson; D Y Sue; K Wasserman; B J Whipp
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-11

7.  Factors influencing estimated oxygen uptake during exercise testing soon after myocardial infarction.

Authors:  W L Haskell; W Savin; N Oldridge; R DeBusk
Journal:  Am J Cardiol       Date:  1982-08       Impact factor: 2.778

8.  Effect of beta-adrenergic blockade on the results of exercise testing related to the extent of coronary artery disease.

Authors:  S W Ho; M J McComish; R R Taylor
Journal:  Am J Cardiol       Date:  1985-02-01       Impact factor: 2.778

9.  Prediction of the frequency and duration of ambulatory myocardial ischemia in patients with stable coronary artery disease by determination of the ischemic threshold from exercise testing: importance of the exercise protocol.

Authors:  J A Panza; A A Quyyumi; J G Diodati; T S Callahan; S E Epstein
Journal:  J Am Coll Cardiol       Date:  1991-03-01       Impact factor: 24.094

10.  The safety of maximal exercise testing.

Authors:  L Gibbons; S N Blair; H W Kohl; K Cooper
Journal:  Circulation       Date:  1989-10       Impact factor: 29.690

View more
  20 in total

Review 1.  A systematic comparison of exercise training protocols on animal models of cardiovascular capacity.

Authors:  Rui Feng; Liyang Wang; Zhonguang Li; Rong Yang; Yu Liang; Yuting Sun; Qiuxia Yu; George Ghartey-Kwansah; Yanping Sun; Yajun Wu; Wei Zhang; Xin Zhou; Mengmeng Xu; Joseph Bryant; Guifang Yan; William Isaacs; Jianjie Ma; Xuehong Xu
Journal:  Life Sci       Date:  2018-12-03       Impact factor: 5.037

2.  Peak oxygen uptake. Myth and truth about an internationally accepted reference value.

Authors:  T Meyer; J Scharhag; W Kindermann
Journal:  Z Kardiol       Date:  2005-04

3.  A pilot study to assess the feasibility of a submaximal exercise test to measure individual response to cardiac medication in dogs with acquired heart failure.

Authors:  L Ferasin; S Marcora
Journal:  Vet Res Commun       Date:  2007-01-25       Impact factor: 2.459

4.  Evaluation of health promotion programmes in severe mental illness: theory and practice.

Authors:  Fenneke M van Hasselt; Paul F M Krabbe; Maarten J Postma; Anton J M Loonen
Journal:  Int J Methods Psychiatr Res       Date:  2014-12-09       Impact factor: 4.035

Review 5.  Exercise-Induced Anaphylaxis: Literature Review and Recent Updates.

Authors:  Matthew P Giannetti
Journal:  Curr Allergy Asthma Rep       Date:  2018-10-26       Impact factor: 4.806

6.  Pacing to reduce refractory angina in patients with severe coronary artery disease: a crossover pilot trial.

Authors:  Craig M Stolen; Yui-Ming Lam; Chung-Wah Siu; Chu-Pak Lau; J Anthony Parker; Thomas H Hauser; Hung-Fat Tse
Journal:  J Cardiovasc Transl Res       Date:  2011-10-26       Impact factor: 4.132

7.  Effects of altitude on exercise level and heart rate in patients with coronary artery disease and healthy controls.

Authors:  S T de Vries; P Komdeur; S Aalbersberg; G C van Enst; A Breeman; A W J van 't Hof
Journal:  Neth Heart J       Date:  2010-03       Impact factor: 2.380

8.  Orthopaedic surgeons' cardiovascular response during total hip arthroplasty.

Authors:  Marko Bergovec; Dubravko Orlic
Journal:  Clin Orthop Relat Res       Date:  2008-01-10       Impact factor: 4.176

Review 9.  Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association.

Authors:  Tiffany M Powell-Wiley; Paul Poirier; Lora E Burke; Jean-Pierre Després; Penny Gordon-Larsen; Carl J Lavie; Scott A Lear; Chiadi E Ndumele; Ian J Neeland; Prashanthan Sanders; Marie-Pierre St-Onge
Journal:  Circulation       Date:  2021-04-22       Impact factor: 29.690

10.  Real-time cine and myocardial perfusion with treadmill exercise stress cardiovascular magnetic resonance in patients referred for stress SPECT.

Authors:  Subha V Raman; Jennifer A Dickerson; Mihaela Jekic; Eric L Foster; Michael L Pennell; Beth McCarthy; Orlando P Simonetti
Journal:  J Cardiovasc Magn Reson       Date:  2010-07-12       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.